Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MEGACOR Diagnostik is an Austrian veterinary in vitro diagnostics company focused on rapid and laboratory-based tests for veterinarians, veterinary clinics, and veterinary laboratories. The company develops and distributes diagnostic products for small and large animals, with strengths in detecting bacterial, viral, and parasitic pathogens, associated antibodies, as well as veterinary-relevant hormones and inflammation markers. Its commercial portfolio includes FASTest rapid antigen and antibody assays, MegaFLUO immunofluorescence tests, MegaELISA assays, and microbiology-oriented products such as MYKODERMOASSAY. The business is oriented toward point-of-care and laboratory veterinary diagnostics rather than therapeutics or drug development. MEGACOR appears to operate as an active private company headquartered in Hörbranz, Vorarlberg, Austria.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MEGACOR Diagnostik.